Kuo, Yur-Ren <br/><br/>
Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury.  [electronic resource] 

 -  The Journal of surgical research  Sep 2002 
 - 50-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-4804 
<br/><br/><label>Standard No.: </label>10.1006/jsre.2002.6500  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Adenosine Diphosphate--pharmacology<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Blood Platelets--drug effects<br/>Dose-Response Relationship, Drug<br/>Endothelium, Vascular--drug effects<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Ischemia--physiopathology<br/>Male<br/>P-Selectin--metabolism<br/>Platelet Activation--drug effects<br/>Platelet Aggregation--drug effects<br/>Platelet Count<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Rats<br/>Rats, Inbred Lew<br/>Regional Blood Flow--drug effects<br/>Reperfusion Injury--physiopathology<br/>Skin--blood supply<br/>Surgical Flaps--physiology<br/>Time Factors<br/>Tissue Survival--drug effects